Stay updated on Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Sign up to get notified when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.

Latest updates to the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating an incremental update to the page metadata without changing the study information.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update represents a version bump rather than a substantive modification to the study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag on the page updated to v3.6.3 from v3.6.2. This reflects a minor site software update and does not modify the study details or user-facing content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, representing a newer platform revision shown on the site. It appears to be a maintenance/version-tracking change rather than content changes.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page now states 'No longer looking for participants' and adds sections to help readers interpret the study record ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). The heading for the Intervention/Treatment section was standardized (Intervention / Treatment removed) and the page revision updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check66 days agoChange DetectedThe revision label on the page has been updated from v3.5.4 to v3.5.5. This indicates a minor update to the page rather than a change to its content.SummaryDifference0.0%

Stay in the know with updates to Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Safety of Dapagliflozin & Saxagliptin Clinical Trial page.